QCM
ORIC icon

Quantinno Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History

Quantinno Capital Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$323K Buy
25,526
+2,170
+9% +$24.6K ﹤0.01% 2990
2025
Q4 		$191K Buy
23,356
+11,093
+90% +$128K ﹤0.01% 3062
2025
Q3 		$147K Buy
+12,263
New +$129K ﹤0.01% 2836

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Quantinno Capital Management's ORIC Position: Q1 2026 in Review

Quantinno Capital Management increased its Oric Pharmaceuticals (ORIC) stake by 9.3% in Q1 2026, buying an estimated $24.6K and bringing the position to 25,526 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #2990.

Quantinno Capital Management first reported a position in ORIC in Q3 2025 and has held it in 3 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Quantinno Capital Management held 25,526 shares of Oric Pharmaceuticals worth $323K as of Q1 2026.
  • Quantinno Capital Management bought 2,170 Oric Pharmaceuticals shares in Q1 2026, an estimated $24.6K.
  • Oric Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2990 holding.
  • Quantinno Capital Management first reported a position in Oric Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.